Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
4(17%)
Results Posted
35%(6 trials)
Terminated
1(4%)

Phase Distribution

Ph early_phase_1
2
8%
Ph phase_2
3
13%
Ph phase_3
2
8%
Ph phase_4
4
17%
Ph phase_1
2
8%
Ph not_applicable
11
46%

Phase Distribution

4

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution24 total trials
Early Phase 1First-in-human
2(8.3%)
Phase 1Safety & dosage
2(8.3%)
Phase 2Efficacy & side effects
3(12.5%)
Phase 3Large-scale testing
2(8.3%)
Phase 4Post-market surveillance
4(16.7%)
N/ANon-phased studies
11(45.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

89.5%

17 of 19 finished

Non-Completion Rate

10.5%

2 ended early

Currently Active

4

trials recruiting

Total Trials

24

all time

Status Distribution
Active(5)
Completed(17)
Terminated(2)

Detailed Status

Completed17
Recruiting3
Terminated1
Withdrawn1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
24
Active
4
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (8.3%)
Phase 12 (8.3%)
Phase 23 (12.5%)
Phase 32 (8.3%)
Phase 44 (16.7%)
N/A11 (45.8%)

Trials by Status

terminated14%
withdrawn14%
completed1771%
active_not_recruiting14%
recruiting313%
not_yet_recruiting14%

Recent Activity

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more
NCT06811038Phase 3

iCanQuit Smoking Cessation Among Hispanic Adults

Not Yet Recruiting
NCT04971954Not Applicable

Using Nicotine to Reverse Age-related Auditory Processing Deficits

Recruiting
NCT05030272Not Applicable

Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings

Completed
NCT05413122Phase 2

Evaluating Smoking Cessation Interventions for PWH in South Africa

Recruiting
NCT03398876Phase 1

A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers

Completed
NCT05290025Not Applicable

Easy Access to Smoking Cessation for People Receiving Opioid Agonist Therapy Who Are Smoking Tobacco

Active Not Recruiting
NCT04384562Not Applicable

Studying the Role of Brain Molecules for Decision Making

Completed
NCT05018117Early Phase 1

Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex

Recruiting
NCT05060965Early Phase 1

Inpatient Smoking Cessation Pilot Program

Withdrawn
NCT05649241Not Applicable

QuitAid Pilot Feasibility Trial

Completed
NCT02513069Not Applicable

Mobile Contingency Management for Smoking Cessation in Returning US Veterans

Completed
NCT03836560Not Applicable

Comparing the Effectiveness of Combined NRT With Single NRT in Primary Care Clinics in Hong Kong

Completed
NCT00710034Phase 2

Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine

Completed
NCT01662115Phase 4

Nicotine Gum Recovery After Colorectal Surgery

Terminated
NCT02452125Not Applicable

The Effects of Nicotine Chewing Gum in Parkinson's Disease

Completed
NCT01208935Phase 2

Safety, Tolerability and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Dependence

Completed
NCT01087905Phase 4

Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines

Completed
NCT01122238Phase 4

Identifying Treatments to Motivate Smokers to Quit

Completed
NCT02356913Phase 1

Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum

Completed
NCT01084707Not Applicable

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
24